Pharmaceutical Formulation Comprising Ezetimibe

Patent No. EP2217214 (titled "Pharmaceutical Formulation Comprising Ezetimibe") was filed by Assia Chemical Industries on Dec 9, 2008. The application was issued on Jul 19, 2017.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BÜLLE DR., JANApr 19, 2018BÜLLE, JAN
WITTKOPPApr 19, 2018HAMM & WITTKOPP
HOFFMANN EITLEApr 18, 2018HOFFMANN EITLE
HGFApr 16, 2018HARRISON GODDARD FOOTE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2217214

ASSIA CHEMICAL INDUSTRIES
Application Number
EP08859677A
Filing Date
Dec 9, 2008
Status
Revoked
May 1, 2026
Publication Date
Jul 19, 2017